Pure Global

LIAISON fPSA - India CDSCO Medical Device Registration

LIAISON fPSA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000113_43f820ee9024b6f081e8d9bd085d3bb9_9756f8ca509b40695486b4b057d77831. This device is marketed under the brand name LIAISON fPSA. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
LIAISON fPSA
UID: IMP/IVD/2019/000113_43f820ee9024b6f081e8d9bd085d3bb9_9756f8ca509b40695486b4b057d77831

Brand Name

LIAISON fPSA

Device Class

Class C

Approving Authority

CDSCO

Product Information

In vitro assay for the quantitative determination of free human prostate-specific antigen (LIAISON fPSA) in human serum and plasma (LIAISON fPSA). The test has to be performed on the LIAISON® Analyzer family

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing